ZAMPIERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.332
AS - Asia 2.919
EU - Europa 2.427
SA - Sud America 277
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 55
OC - Oceania 37
Totale 9.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.230
RU - Federazione Russa 1.043
SG - Singapore 919
CN - Cina 877
IT - Italia 574
HK - Hong Kong 295
KR - Corea 261
VN - Vietnam 217
BR - Brasile 205
FI - Finlandia 132
IE - Irlanda 129
DE - Germania 125
GB - Regno Unito 87
SE - Svezia 86
FR - Francia 84
IN - India 82
TR - Turchia 62
BD - Bangladesh 60
CA - Canada 52
AU - Australia 37
AR - Argentina 36
JO - Giordania 33
ID - Indonesia 32
JP - Giappone 30
MX - Messico 28
ES - Italia 26
NL - Olanda 25
CH - Svizzera 21
DK - Danimarca 18
PL - Polonia 16
EG - Egitto 15
EC - Ecuador 12
IQ - Iraq 12
NG - Nigeria 11
UA - Ucraina 9
GR - Grecia 8
ZA - Sudafrica 8
CL - Cile 7
BE - Belgio 6
CZ - Repubblica Ceca 6
MA - Marocco 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BJ - Benin 5
JM - Giamaica 5
NO - Norvegia 5
RS - Serbia 5
VE - Venezuela 5
AL - Albania 4
HN - Honduras 4
PK - Pakistan 4
PT - Portogallo 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
KE - Kenya 3
MY - Malesia 3
UZ - Uzbekistan 3
BH - Bahrain 2
CR - Costa Rica 2
GY - Guiana 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BM - Bermuda 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
ZM - Zambia 1
Totale 9.048
Salva come PNG Salva come JPEG
Città #
Santa Clara 880
Singapore 682
Ashburn 472
Hefei 317
Hong Kong 263
Seoul 258
San Jose 201
Dublin 127
North Bergen 121
Milan 110
Council Bluffs 96
Helsinki 90
Beijing 85
Los Angeles 84
Ho Chi Minh City 77
Florence 58
Munich 58
New York 57
Chandler 56
Moscow 51
Hanoi 50
Rome 44
Kent 42
The Dalles 42
Lauterbourg 41
Fairfield 37
Buffalo 36
Dallas 36
Melbourne 36
Shanghai 31
Istanbul 29
Jakarta 28
Seattle 27
Tokyo 27
Mumbai 24
Altamura 23
Lawrence 23
Houston 22
Frankfurt am Main 21
Turku 21
London 20
Bengaluru 19
Lappeenranta 19
Copenhagen 18
Ann Arbor 17
Lakewood 17
Naples 17
Woodbridge 17
Bern 16
Boston 16
Orem 16
Phoenix 16
Adapazarı 15
Cambridge 15
Toronto 15
Figino 14
Princeton 14
São Paulo 14
West Jordan 14
Chennai 12
Chicago 12
Abuja 11
Atlanta 11
Düsseldorf 11
Mudanya 11
Prato 11
Da Nang 10
Nuremberg 10
Warsaw 10
Yubileyny 10
Hillsboro 9
Palermo 9
Paris 9
San Francisco 9
Amsterdam 8
Manchester 8
Pune 8
Bologna 7
Madrid 7
Medford 7
Mexico City 7
Montreal 7
Poplar 7
Rio de Janeiro 7
San Diego 7
Stockholm 7
Wilmington 7
Asyut 6
Biên Hòa 6
Boardman 6
Johannesburg 6
Miano 6
Pisa 6
Turin 6
Athens 5
Baghdad 5
Bayreuth 5
Belgrade 5
Brussels 5
Buenos Aires 5
Totale 5.413
Salva come PNG Salva come JPEG
Nome #
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 372
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 255
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 254
Standard Therapy in Cardiac Amyloidosis 211
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 211
[Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy] 204
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 203
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 203
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 201
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 192
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 189
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 187
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 181
Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis 180
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 177
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 174
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 172
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 172
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 168
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 167
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 167
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 167
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 165
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 164
Racial Differences in Val122Ile-Associated Transthyretin Cardiac Amyloidosis 163
Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease 161
SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series 161
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 160
Diagnostic Pathways to Wild-Type Transthyretin Amyloid Cardiomyopathy: a Multicenter Network Study 158
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 158
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 157
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 156
Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease? 155
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 154
Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama 153
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 152
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 150
Prevalence of carpal tunnel syndrome in patients with transthyretin cardiac amyloidosis 149
Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery 147
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 146
Stage-specific therapy for hypertrophic cardiomyopathy 146
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 142
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 141
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 141
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 139
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 134
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 133
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis 127
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 121
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 118
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 115
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition 98
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-study 79
Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation 78
Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis 58
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data 51
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 34
Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63 25
Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options 19
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis 17
Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy 3
Totale 9.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022122 0 4 5 9 4 10 6 6 16 12 19 31
2022/2023543 22 75 15 16 55 81 102 34 58 18 28 39
2023/2024548 30 39 46 30 36 68 33 132 12 54 32 36
2024/20253.015 86 282 161 485 759 378 87 151 148 74 169 235
2025/20264.210 400 551 573 388 405 149 452 225 332 296 151 288
2026/2027556 258 298 0 0 0 0 0 0 0 0 0 0
Totale 9.135